Top 50 Medical Device VC Funds & Investors in Italy (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
CDP Venture Capital
VC Fund
|
8 | Italy, United States, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $483k–$23M |
|
Italian Angels for Growth
VC Fund
|
6 | Italy, United States, United Kingdom | Seed, Angel, Series A | Software, E-Commerce, Health Care | $219k–$14M |
|
Panakes Partners
VC Fund
|
6 | Italy, Switzerland, United Kingdom | Series B, Series A, Series C | Health Care, Medical, Biotechnology | $4.4M–$110M |
|
EUREKA! Venture SGR
VC Fund
|
5 | Italy | Seed, Venture - Series Unknown | Nanotechnology, Manufacturing, Electronics | $419k–$6.2M |
|
ENEA Tech e Biomedical
VC Fund
|
5 | Italy, Finland | Venture - Series Unknown, Series A, Grant | Health Care, Biotechnology, Medical Device | $530k–$21M |
|
Principia SGR
VC Fund
|
5 | Italy, United States, United Kingdom | Series A, Seed | Health Care, Biotechnology, Software | $329k–$7.7M |
|
A11 Venture
VC Fund
|
4 | Italy, United States | Seed, Pre-Seed, Series A | E-Commerce, Biotechnology, Medical Device | $419k–$1.4M |
|
Innogest Capital
VC Fund
|
4 | Italy, United States, Spain | Series A, Series B | Health Care, Medical, Medical Device | $1.1M–$29M |
|
Vertis
VC Fund
|
3 | Italy, United States, United Kingdom | Seed, Series A | Software, Health Care, Biotechnology | $823k–$11M |
|
Club degli Investitori
VC Fund
|
3 | Italy, Switzerland, United Kingdom | Seed, Series A, Pre-Seed | Software, Health Care, E-Commerce | $197k–$30M |
|
Bios Line Holding
VC Fund
|
2 | Italy | Seed, Series A | Sports, Leisure, E-Commerce | $545k–$2.7M |
|
Italian Angels for Biotech
VC Fund
|
2 | Italy | Seed, Pre-Seed | Health Care, Biotechnology, Pharmaceutical | $545k–$2M |
|
Healthware Ventures
VC Fund
|
2 | Italy, Austria, United States | Seed, Pre-Seed, Series A | Health Care, Personal Health, PaaS | $823k–$4.4M |
|
a|impact
VC Fund
|
2 | Italy | Seed, Venture - Series Unknown, Series A | Health Care, Fashion, Wellness | $380k–$3.3M |
|
LIFTT
VC Fund
|
2 | Italy, United Kingdom, France | Seed, Series A, Venture - Series Unknown | Biotechnology, Software, Manufacturing | $255k–$118M |
|
Intesa Sanpaolo
VC Fund
|
2 | Italy, United Kingdom, United States | Debt Financing, Post-IPO Debt, Convertible Note | Energy, Manufacturing, Renewable Energy | $299k–$2.5B |
|
UniCredit
VC Fund
|
2 | Italy, Germany, Spain | Debt Financing, Post-IPO Debt, Pre-Seed | Renewable Energy, Energy, Manufacturing | $197k–$2.1B |
|
Invitalia Ventures
VC Fund
|
2 | Italy, United States, United Kingdom | Series A, Seed | Software, Medical, B2B | $658k–$6.2M |
|
Equiter
VC Fund
|
1 | Italy | Seed, Series B | Medical, Health Care, Information Technology | $2.2M–$4M |
|
Sistema Investimenti
VC Fund
|
1 | Italy | Seed | Mobile, Medical, Health Care | $500k–$2.1M |
|
Toscana Next Fund
VC Fund
|
1 | Italy | Seed, Series A | Manufacturing, Robotics, Electronics | $1.6M–$5.8M |
|
Manilo Marocco Partners
VC Fund
|
1 | Italy | Series A | Wellness, Psychology, Health Care | |
|
Green Arrow Capital
VC Fund
|
1 | Italy, United Kingdom | Seed, Series A | Health Care, Software, Biotechnology | $1.5M–$2.2M |
|
Capital Cell
VC Fund
|
1 | Spain, United States, United Kingdom | Equity Crowdfunding, Seed | Health Care, Biotechnology, Medical | |
|
Rancilio Cube
VC Fund
|
1 | United States, Italy, Germany | Seed, Series A, Series B | E-Commerce, Software, Financial Services | |
|
Sefea Impact
VC Fund
|
1 | Italy | Medical, Health Care, Medical Device | ||
|
Simon Fiduciaria
VC Fund
|
1 | Italy, United Kingdom | Seed, Series B | Therapeutics, Simulation, Biotechnology | |
|
50 Partners Health
VC Fund
|
1 | ||||
|
Estor
VC Fund
|
1 | Italy | Seed | Health Care, Biotechnology, Medical Device | |
|
Spindial Group
VC Fund
|
1 | Italy | Medical, Health Care, Biotechnology | ||
|
I.A.C.E.R. srl
VC Fund
|
1 | Italy | Seed | Wellness, Health Care, Medical Device | |
|
Fondazione Golinelli
VC Fund
|
1 | Italy | Seed, Pre-Seed | FinTech, Financial Services, AgTech | $146k–$534k |
|
Embed Capital
VC Fund
|
1 | Italy, Switzerland, United Kingdom | Seed, Pre-Seed | Information Technology, Mobile, Health Care | $132k–$2.1M |
|
Sviluppo Imprese Centro Italia
VC Fund
|
1 | Italy | Seed, Angel | Software, Food Processing, Food and Beverage | $584k–$668k |
|
Global Payments SpA
VC Fund
|
1 | Italy | Seed | FinTech, Wearables, Biometrics | |
|
RedSeed Ventures
VC Fund
|
1 | Italy, Israel, United States | Seed, Series A, Series B | Software, Information Technology, Retail | $669k–$16M |
|
Roca X
VC Fund
|
1 | Romania, United Kingdom, Italy | Seed, Pre-Seed, Convertible Note | Software, Information Technology, SaaS | $55k–$2.6M |
|
GM&C Life Sciences Fund
VC Fund
|
1 | United Kingdom, Italy, Germany | Seed, Series A | Health Care, Biotechnology, Medical | $131k–$4.1M |
|
Fountain Healthcare Partners
VC Fund
|
1 | Ireland, United States, France | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $3.3M–$110M |
|
Atlante Ventures
VC Fund
|
1 | Italy, United States, Israel | Seed, Series A | Software, Hardware, Biotechnology | $150k–$3.5M |
|
RoboIT
VC Fund
|
1 | Italy | Seed, Series A, Pre-Seed | Manufacturing, Robotics, Artificial Intelligence | $867k–$81M |
|
Lazio Innova
VC Fund
|
1 | Italy, United Kingdom | Seed, Pre-Seed, Grant | Health Care, Software, Biotechnology | $22k–$1.9M |
|
Amazon Alexa Fund
VC Fund
|
1 | United States, United Kingdom, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $120k–$120M |
|
Cysero
VC Fund
|
1 | Italy, United States | Seed, Venture - Series Unknown, Series A | Robotics, Information Technology, Autonomous Vehicles | $1.4M–$5.5M |
|
Andera Partners
VC Fund
|
1 | France, United States, Germany | Series B, Private Equity, Series A | Biotechnology, Health Care, Medical | $7M–$237M |
|
SFEM Italia
VC Fund
|
1 | Italy | Seed | Big Data, Software, Health Care | |
|
UV-Cap
VC Fund
|
1 | Italy, Germany | Seed, Series A | Personal Health, Big Data, Software | |
|
Si14
VC Fund
|
1 | Italy | Seed | Medical, mHealth, Diabetes | |
|
SIMEST
VC Fund
|
1 | Italy, San Marino, Saudi Arabia | Series A, Series B, Venture - Series Unknown | Manufacturing, FinTech, Aerospace | $4.1M–$24M |
|
F3F
VC Fund
|
1 | Italy | Series A, Series B, Series C | Hardware, Hospital, Software | $3.3M–$9.2M |
| Access all 105 VC funds in Italy Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 295
- Round size: Seed $483k–$7.7M; Series A $3.3M–$23M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $197M in 2021
Portfolio highlights
- Evja — Evja supports growers in optimizing the management and monitoring of irrigation, nutrition and protection of their crops through the use of OPI, the most advanced system for precision agriculture .
- Mopso — Discover Mopso's anti money laundering detection system. Visit our website and try a 30 minutes free demo with one of our experts.
- ALLSIDES — Covision Media specializes in creating high-quality, relightable 3D models using their industrial 3D scanners. These scanners capture detailed surface information and PBR textures, and are designed for easy integration into virtual environments.
IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.
Show more...Investment focus
- Industry: Software, E-Commerce, Health Care
- Stage:Seed, Angel, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 105
- Round size: Seed $329k–$5.1M; Angel $219k–$987k; Series A $3M–$14M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Cato AI — Search, analyze and bid on Italian public tenders with AI, automating the manual work for bid offices and sales teams.
- AUDIOGEN — Generate your sounds with AI. Create an infinite world of sounds - sound effects, samples, and music, instantly. Get Started Free.
- Alomana — Autonomous systems for enterprise
Panakès Partners is a Venture Capital firm, based in Milan, which invests in the most ambitious companies and teams, developing revolutionary technologies and products, in the field of life sciences, aiming to improve the lives of people around the world. Panakès, founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni, has 250million under management.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series B, Series A, Series C
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 42
- Round size: Series A $4.4M–$79M; Series B $10M–$60M; Series C $18M–$110M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Neuromod Devices — Neuromod is the global medical device company that developed Lenire, the FDA Approved tinnitus treatment device.
- DISCO Pharmaceuticals — DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.
- Endovascular Engineering — Endovascular Engineering is a medical technology company focused on developing and deploying advanced clot removal solutions for the treatment of venous thromboembolism. It specializes in thrombectomy technologies designed to improve clinical outcomes and procedural efficiency in minimally invasive vascular interventions. The company’s flagshipinnovation is the Hēlo™ Thrombectomy System, a catheter-based device that uses a combination of mechanical agitation and physician-controlled aspiration to remove blood clots. Its technology emphasizes features such as a self-expanding funnel design and dual-action functionality to enhance clot engagement and navigation through complex anatomies. Endovascular Engineering primarily serves healthcare providers, including interventional cardiologists and radiologists, supporting the treatment of conditions such as pulmonary embolism and deep vein thrombosis.
Eureka! is the first independent Italian venture capital Asset Management company exclusively focused on deep tech investments
Show more...Investment focus
- Industry: Nanotechnology, Manufacturing, Electronics
- Stage:Seed, Venture - Series Unknown
- Geography: Italy
Investor stats
- Total investments: 38
- Round size: Seed $419k–$4.1M; Venture - Series Unknown $2.2M–$6.2M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- BeNewtral — Il futuro delle costruzioni rispetta l'ambiente
- CareGlance — CareGlance is the provider of real-time monitoring systems based on SS-OCT technology. Fast, precise and developed for the industry!
- BeDimensional — New Material Solution
ENEA Tech e Biomedical is a private foundation. It seeks to encourage the strengthening of research, development, and industrial reconversion of the biomedical sector.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Venture - Series Unknown, Series A, Grant
- Geography: Italy, Finland
Investor stats
- Total investments: 13
- Round size: Series A $3.3M–$7.7M; Venture - Series Unknown $530k–$21M
- Lead/follow: 92% lead, 8% follow
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
- Recornea — Recornea is a developer of a corneal medical device to restore the physiological curvature of the cornea with clear and predictable clinical outcomes.
- Health Triage — Health Triage, crea nuove tecnologie per offrire modelli innovativi di diagnosi clinica, identificazione e cura delle malattie oncologiche.
Principia is an Italian Venture Capital firm with over Eur 80M under management. Currently Principia has two funds investing in digital start ups and expansion capital opportunities and in particular cases, we invest also in seed opportunities.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 50
- Round size: Seed $329k–$3.3M; Series A $1.5M–$7.7M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $187M in 2014
Portfolio highlights
- KLISBio — KLISBio is a clinical-stage regenerative medicine company focused on developing innovative technology platforms based entirely on natural silk fibroin. The company, headquartered in Milan, Italy, currently has several assets under development, such as vascular graft, bone graft substitutes, rotator cuff repair, drug release, and a first-in-humanstudy on nerve repair that is ongoing at the University of Zurich, Switzerland
- ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
- WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
A11-Venture investe nel capitale di startup innovative nei settori della robotica, automazione, meccatronica, cleantech, web e IT. Facilita la nascita e lo sviluppo di business innovativi globali per il futuro dell'economia locale. Contribuisce a costruire aziende, lavoro qualificato, brevetti, innovazione capaci di rilanciare e riportareinvestimenti e risorse sul territorio. I soci di A11 Venture credono fermamente nell’innovazione grazie a ciò è possibile crescere per linee esterne diversificando i propri investimenti, grazie ad un portafoglio di imprese, con una forte risk mitigation derivante dalla gestione professionale di tutti processi: scouting, team building, investimenti, management degli investimenti, accelerazione e disinvestimento.
Show more...Investment focus
- Industry: E-Commerce, Biotechnology, Medical Device
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy, United States
Investor stats
- Total investments: 14
- Round size: Seed $419k–$1.4M; Pre-Seed $734k–$1M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Reefilla — Reefilla EV charging services: recharge your car anywhere, anytime
- AdapTronics — AdapTronics is a deep-tech startup that produces adaptive mechatronic devices to make logistics sustainable on Earth and in space. Its adaptive mechatronics technology offers an alternative based on a multifunctional electrostatic membrane that allows the gripping and manipulation of objects of any shape. In addition, it offers a thin-filmtechnology with sensor capabilities that becomes adhesive when electrically activated.
- Neuron Guard — Neuron Guard, recognized as the best European startup in HEALTH category (Startup Europe Awards - SEUA 2017), is developing a life-saving medical device that aims to become the standard of care for Targeted Temperature Management (TTM) therapy. Every 7 seconds around the world a person suffers of Acute Brain Damage because of CardiovascularDiseases (CVD) and Traumatic Brain Injury (TBI). They are the most costly and prevalent killers in the last 15 years (15 million deaths by CVD in 2015), and the leading cause of disability (the global incidence rate of TBI is 200 per 100k people per year). WHO estimated a global expenditure of $ 330 billion in 2015, but it is going to increase sharply: $ 4 trillion in 2025 - including premature death, disability, and health care costs - just for CVD in LMICs. Temperature is a vital body parameter. It regulates all cellular functions so its management is essential for the good outcome of patients in several medical conditions such as cardiac arrest, stroke, traumatic brain injury, neuro and cardiac surgery, epilepsy, migraine and oncology. Regulating body temperature at a desired level makes all other treatments more effective. The most modern medical approach is the target temperature management, where physicians try to maintain the most favourable temperature for the patient for up to 24-36 hours, preventing excessive warming (fever) or cooling.Our device is a targeted temperature management system composed by a THERAPEUTIC COLLAR POWERED BY A SMART CONTROL UNIT (the size of a small briefcase). The collar transforms the neck into a natural heat exchanger exploiting several physiological and anatomical characteristics of the human body. It is quicker to act on brain tissue but can also function as total body temperature adjusting device if required. A disposable protective shield makes cleaning the collar after each use simple while featuring an optimal safety profile both in term of pathogens and allergens. The control unit collects all the data of the treatment and transmits them to the Emergency Response System. Our mission is to improve the safety of patients on the roadside, at home or in the workplace, and to reduce the costs of chronic care. In fact, Neuron Guard aims to be the only device that can be used in every circumstance, inside and outside the hospital, and allow the user to fully manage the temperature of the patient warming and cooling as necessary. Our vision is to have a Neuron Guard kit in every public place just like the Automatic External Defibrillator (AED) to empower bystanders to immediately react in case of emergency. Under this perspective our device becomes a connected-intelligent platform that takes care of the patient, connects the scene with the Emergency Response System transmitting vital data to improve the readiness and effectiveness of professional intervention.The device is patented in Italy, USA and China. We have made several prototypes in collaboration with Italian and English companies, such as Tecno Elettra Impianti and TWI, tested it in laboratory and published the experimental results on the NeuroCritical Care Journal. We have also conducted a GAP Analysis with another English consulting firm (CDP) and we are testing the human prototype internally. We are seeking to raise 2.5M€ to complete the pre-industrialization, with design and construction of the human device for the pilot trial, finalized the regulatory clearance and launch it into the market in 2019.
We are investors in companies that make the difference. We partner with hard-working entrepreneurial visionaries
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series B
- Geography: Italy, United States, Spain
Investor stats
- Total investments: 68
- Round size: Series A $1.1M–$11M; Series B $2.7M–$29M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — raised $99M in 2015
Portfolio highlights
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- Renovacor — Renovacor is a preclinical‑stage biopharmaceutical company focused on developing transformative gene therapy‑based treatments for cardiovascular disease.Renovacor’s lead program is a recombinant adeno-associated virus (AAV)‑based gene therapy for patients suffering from dilated cardiomyopathy (DCM) due to mutations in the Bcl2‑associatedathanogene 3 (BAG3) gene.Dilated cardiomyopathy is a condition affecting over 3 million patients in the US and growing steadily. Many patients develop DCM due to ischemic heart disease. Recently subpopulations have been identified that develop DCM due to mutations in specific genes that have been shown to result in the development of DCM. One of these specific genes is the BAG3 gene. The prevalence of disease‑causing BAG3 haploinsufficiency is estimated at approximately 35,000 individuals in the United States, representing an orphan disease by FDA guidelines. It is estimated a similar number of DCM patients with BAG3 mutations exist in Europe. These patients are typically younger and progress to end-stage heart failure sooner than patients with ischemic heart disease. Currently, DCM patients with a BAG3 mutation are treated with standard of care for heart failure. Despite improvements in pharmacotherapy and care, the five‑year survival of a patient with DCM is only 50%. The development of a BAG3 gene replacement therapy for patients with DCM that carry BAG3 mutations could potentially prevent the progression of disease in this otherwise healthy population of young adults.
- BetaGlue Technologies — BetaGlue Therapeutics develops innovative targeted cancer therapy solutions using its proprietary YntraDose technology for nuclear medicine.
Capitali e competenze per accelerare l'innovazione. Attraverso fondi di investimento chiusi investiamo in startup, scaleup e PMI innovative
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 70
- Round size: Seed $823k–$4M; Series A $1.5M–$11M
- Lead/follow: 56% lead, 44% follow
- Last fund: Likely still investing — raised $35M in 2021
Portfolio highlights
- Scuter — Scuter is the smart e-scooter sharing service that makes city mobility,simple, enjoyable and sustainable. Scuter is on well on its path toward making a dent in this space.
- Soource — Soource is a B2B Saas product that uses AI applications to help purchasing managers to discover the best market solutions through extensive global research and automated email negotiations with thousands of suppliers worldwide.
- Health Triage — Health Triage, crea nuove tecnologie per offrire modelli innovativi di diagnosi clinica, identificazione e cura delle malattie oncologiche.
Club degli Investitori (Investors Club) is a network of investors and business angels that invest on early-stage SMEs and startups. The community of 300+ Members (entrepreneurs, CEOs, executive managers) actively scouts for investing opportunities on SMEs & startups and invests with a minimum ticket of €200k. The Club supports business byinvesting capital and by leveraging the Members' network and experience.Club degli Investitori is supported by Unicredit and KPMG Italy.
Show more...Investment focus
- Industry: Software, Health Care, E-Commerce
- Stage:Seed, Series A, Pre-Seed
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 114
- Round size: Seed $197k–$8.2M; Pre-Seed $204k–$1.9M; Series A $889k–$30M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Soource — Soource is a B2B Saas product that uses AI applications to help purchasing managers to discover the best market solutions through extensive global research and automated email negotiations with thousands of suppliers worldwide.
- CiaoDott — Automatizza le telefonate, prenotazioni e FAQ del tuo studio medico con CiaoDott, l'assistente vocale AI disponibile 24/7. Provalo gratis.
- Quantum Bridge — Quantum Bridge is a pioneer in Distributed Symmetric Key Exchange (DSKE) technology. It offers quantum-safe cybersecurity products and services. Quantum-safe product and services, Quantum-safe roadmap and quantum-safe solutions implementation.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!investment firm
Show more...Investment focus
- Industry: Sports, Leisure, E-Commerce
- Stage:Seed, Series A
- Geography: Italy
Investor stats
- Total investments: 5
- Round size: Seed $545k–$1.3M; Series A $2.3M–$2.7M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- MgShell — MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures.
- Freedome — Freedome is the leading marketplace for outdoor activities in Italy
Angel group focuses on biotech
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Seed, Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 5
- Round size: Seed $545k–$2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MgShell — MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures.
- CaSRevolution — A novel disease-modifying approach against neurodegeneration
- Metis Precision Medicine — Metis Precision Medicine is a B-Corp founded with the vision of bringing powerful cancer therapies to patients in need. Metis owns the intellectual property of a suite of anti-Met monoclonal antibodies (mAbs), with different and unique mechanisms of action, and is currently seeking investors, biotech or pharmaceutical companies interested inacquiring the relevant platform technology on a global basis.
Healthware Ventures is the corporate venture capital arm of Healthware Group
Show more...Investment focus
- Industry: Health Care, Personal Health, PaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy, Austria, United States
Investor stats
- Total investments: 8
- Round size: Seed $823k–$4.4M; Pre-Seed $1M–$1.3M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- PatchAi — Improve patient engagement and experience in clinical trials and standard care. Discover Patchai solution.
- 1000Farmacie — 1000Farmacie is the leading Pharmacy Marketplace in Italy. Though a network of independent Pharmacies we deliver faster!
- Newel Health — Certified digital medical devices for chronic disease, built to the standard the problem deserves.
a|impact invests in the prevailing form of equity or quasi-equity, focusing our operations mainly on companies.
Show more...Investment focus
- Industry: Health Care, Fashion, Wellness
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Italy
Investor stats
- Total investments: 11
- Round size: Seed $380k–$1.5M; Venture - Series Unknown $418k–$3.3M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- Id.Eight — D.EIGHT is a brand of eco-friendly sneakers produced from food industry waste and recycled material.
- AmaliaCare — AmaliaCare is a socially conscious company that gives a new perspective to the world of aged care. AmaliaCare are the premier digital employment agency, specializing in profiling the ideal domestic workers using cutting-edge technology for families seeking dependable assistance for loved ones who are no longer self-sufficient.
- HARG - Healthy Aging Research Group — HARG researches, develops, and markets dehydrated food preparations with modified textures. The company ensures nutritional principles are the same or even enhanced when compared to those of a typical meal by using only natural ingredients. The R&D activity done in collaboration with the University of Genoa ensures scientific efficacy. HARGseeks to enhance the health and wellbeing of those who struggle with swallowing.
A not-only-profit operating investment company, eager to create a bridge between innovative ideas, territory and capital.
Show more...Investment focus
- Industry: Biotechnology, Software, Manufacturing
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Italy, United Kingdom, France
Investor stats
- Total investments: 73
- Round size: Seed $255k–$7.6M; Series A $2.8M–$21M; Venture - Series Unknown $495k–$118M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- CareGlance — CareGlance is the provider of real-time monitoring systems based on SS-OCT technology. Fast, precise and developed for the industry!
- Rainbow Crops — Rainbow Crops is a next-generation Agtech company developing climate-resilient, high-performing crop varieties.
- Wearable Robotics — Wearable Robotics produces and develops wearable robotic systems and exoskeletons for rehabilitation, assistance and human-power augmentation.
Intesa Sanpaolo is a banking group that specializes in wealth management, protection, advisory, and digital orientation. Their products and services include accounts, cards, loans, mortgages, insurance, digital payments, retirement planning, investments, and consulting. It was founded by the merger of Banca Intesa and Sanpaolo IMI.
Show more...Investment focus
- Industry: Energy, Manufacturing, Renewable Energy
- Stage:Debt Financing, Post-IPO Debt, Convertible Note
- Geography: Italy, United Kingdom, United States
Investor stats
- Total investments: 142
- Round size: Post-IPO Debt $112M–$2.5B; Debt Financing $1.1M–$1000M; Convertible Note $299k–$2.2M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- ESAPRO — ESAPRO designs, constructs, and manages plants for the production of electricity from renewable sources.
- Cornaglia — Cornaglia designs, develops, and manufactures metal and plastic components for the automotive industry.
- Aedifica — Aedifica is a listed company that specialises in investments in European healthcare real estate, in particular housing for seniors with care needs.
UniCredit is a pan-European commercial bank offering unique banking services in Italy, Germany, Central and Eastern Europe.
Show more...Investment focus
- Industry: Renewable Energy, Energy, Manufacturing
- Stage:Debt Financing, Post-IPO Debt, Pre-Seed
- Geography: Italy, Germany, Spain
Investor stats
- Total investments: 144
- Round size: Pre-Seed $197k–$197k; Post-IPO Debt $44M–$2.1B; Debt Financing $552k–$913M
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- Banxware — Banxware provides the technology and the funds for business financing of any kind: fully embedded in your platform or as an affiliate solution - all managed by Banxware
- Retina — Retina si occupa di realizzare infrastrutture nel Mezzogiorno per la produzione di biometano dalla conversione dei reflui zootecnici.
- Polo Strategico Nazionale — Scopri Polo Strategico Nazionale: il cloud sovrano per la gestione dei dati e servizi della Pubblica Amministrazione italiana.
Invitalia Ventures SGR manages the “Italia Venture Fund I”, a 87€/Ml sized co-investment fund that invests in early stage operations in Italy. They co-invest up to a maximum of 70% in round A (€ 0.5ML - € 1.5ML) in high growth sectors. Invitalia Ventures, with its network of co-investors not only provides risk capital, but also know-how and anetwork for business development. Main LPs includes the Ministery of Economic Development, the European Investment Bank, Cisco Group, the Sardinian Banking Foundation and Metec Group.They are looking for visionary entrepreneurs who share their passion for innovation. Growth is their mission!!For more information please contact us at info@invitaliaventures.it or visit our website: www.invitaliaventures.it
Show more...Investment focus
- Industry: Software, Medical, B2B
- Stage:Series A, Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 30
- Round size: Seed $658k–$1.6M; Series A $900k–$6.2M
- Lead/follow: 13% lead, 87% follow
- Last fund: May invest from a new fund soon — raised $89M in 2017
Portfolio highlights
- Ecomate — The ESG Rating platform for every company
- BigProfiles — BigProfiles is an Artificial Intelligence Platform designed for Utilities, Telcos, Banks, Insurance companies and Retails.Large companies such as Teleperformance, Eni, Unicef already have already successfully subscribed to our services.BigProfiles is the No-Code Artificial Intelligence Platform for sales and antichurn that predicts thelikelihood to purchase and churn of each customer in a CRM, before proceeding to contact him in a sales or retention campaign.
- Codemotion — Codemotion is the ecosystem devoted to innovation, focused on developers and coding, open to all programming languages and technologies. Pioneering spirits, it scout the future to deliver a first class experience to our people. Codemotion is one of the biggest tech-conferences in Europe, with an international network of 30.000 developers and 350speakers coming from all over the world and from the most important IT realities.Codemotion draw in its main conferences, thousands of attendees eager to discuss about hottest topics: it tailor for them disruptive proposals ranging from mobile to UX, develops, cloud, big data, gamedev, security, methods, languages, web, Internet of things. Codemotion is also a startup, providing a bunch of services and activities, for personal and business customers.
Equiter seleziona, realizza e gestisce investimenti infrastrutturali in capitale di rischio finalizzati allo sviluppo socio-economico del territorio.
Show more...Investment focus
- Industry: Medical, Health Care, Information Technology
- Stage:Seed, Series B
- Geography: Italy
Investor stats
- Total investments: 8
- Round size: Seed $2.2M–$4M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Busforfun — Shared and Green traveling to experience the world of fun#WeTheFun | Busforfun is a young mobility company traveling in a sustainable, safe and low-cost way across Europe. Busforfun vision is a green and shared mobility to experience the world of fun.#WeTheTech | Busforfun is a combination of high tech-startup, e-commerce-platform andtransportation company, Busforfun is going to establish European largest bus network for events in the short time. Thanks to a powerful search engine, business intelligence, an user-friendly booking system and an extensive route network, Busforfun offers travellers the opportunity to experience the world of fun with lower fares.#WeTheGreen | Our low-emission buses comply with the highest safety and environmental standards, so Busforfun offers a sustainable and convenient alternative to cars. With main partner Treedom, Busforfun plants new trees at any travel worldwide.Live Fun Experience in partnership – our concept for successBusforfun provides customers with great offers at lowest budget, through smart network planning, dynamic price management and an adaptive web engine.Busforfun platform is where the innovation and start-up spirit meet the experience and know-how of traditional bus companies and travel agencies.Incredible success can be attributed to the digitalization of old-fashioned bus travel industry: Busforfun has not suppliers or clients: but partners only!
- Easy Rain — Leading a new automotive era: our modular ecosystem of virtual sensors and active hardware makes cars and autonomous platforms truly safe in every condition.
- Faccin Group — Faccin Group leads in manufacturing top tier metal forming & bending machines. Operating as Faccin, Roundo & Boldrini, we offer unparalleled expertise.
Sistema Investimenti is an holding in the form of SpA, established by the will of young professionals and entrepreneurs in Sicily. Sistema Investimenti focus on qualified minorities primarily in companies in the South of Italy with the exception of turnaround/restructuring and distressed.
Show more...Investment focus
- Industry: Mobile, Medical, Health Care
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 2
- Round size: Seed $500k–$2.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Pedius — Pedius is a communication system that allows deaf people to make normal phone calls. Use it in your everyday life to make important calls such as booking doctors appointments or making reservations, or to call family, friends and coworkers.Once you download the smartphone app you can start a conversation by either typing or speaking a message.The recipient will listen on their end and reply, and you will immediately read a transcription of what he or she just said. Pedius gives you the freedom to have real-time conversations when you need to call a plumber, book a table at your favourite restaurant, or talk to your doctor.The Pedius app is especially useful when you need to contact someone accessible only by phone, and it is an excellent help when you need to be careful about your privacy.
- Angiodroid — Angiodroid srl, a medical technology company, focuses on hemodynamics, vascular surgery, and interventional radiology. It offers an automatic injection system for carbon dioxide angiography. Its products include carbon dioxide injector that is used as a contrast medium for pheriperal interventional angiography; and a single use kit, which iscomposed of French catheters and a custom connection line. The company is based in San Lazzaro di Savena, Italy.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Toscana Next Fund is a co-investment fund managed by CDP Venture Capital.
Show more...Investment focus
- Industry: Manufacturing, Robotics, Electronics
- Stage:Seed, Series A
- Geography: Italy
Investor stats
- Total investments: 7
- Round size: Seed $1.6M–$1.9M; Series A $4.9M–$5.8M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Small Pixels — SmallPixels provides video and image from compressed video streams applicable to movies, TV series, surveillance videos, and video chats to users, delivering an experience with reduced streaming expenses.
- Wearable Robotics — Wearable Robotics produces and develops wearable robotic systems and exoskeletons for rehabilitation, assistance and human-power augmentation.
- Next Generation Robotics — Next Generation Robotics is a company that manufactures robotic systems for inspection and monitoring for the railway industry.
Manilo Marocco Partners is an investment firm.
Show more...Investment focus
- Industry: Wellness, Psychology, Health Care
- Stage:Series A
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Restorative Neurotechnologies — Siamo un'azienda di dispositivi medicali certificati per la riabilitazione cognitiva ed il trattamento di disturbi cognitivi post ictus.
Piattaforma indipendente italiana leader negli investimenti alternativi.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Series A
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 10
- Round size: Series A $1.5M–$2.2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Maticmind S.p.A — Maticmind S.p.A is a company that provides ICT and system integration solutions to telecommunications operators.
- Green Future Project — B Corp climate tech che supporta le aziende a raggiungere il net zero e diventare un'azienda sostenibile, riducendo l'impatto ambientale.
- Glomeria Therapeutics — Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis.Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.
Capital Cell is a crowdinvesting platform for biotech and life sciences companies. Mixing VC, business angels, accredited investors, and the power of the crowd, the company is building a global meeting point for companies and researchers working, fostering, and financing tomorrow’s medical science.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Equity Crowdfunding, Seed
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 47
- Lead/follow: no public data
Portfolio highlights
- MgShell — MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures.
- OxyPrem — OxyPrem is a Swiss manufacturer of next-generation medical devices for oxygen-related brain monitoring of preterm infants in real time, using harmless, non-invasive near-infrared light. Our sensors continuously measure local oxygenation with the precision and accuracy that are needed to assist in clinical decision-making for these high-risk patients.
- MSInsight — Explore how our cutting-edge genomic analysis uncovers actionable insights into microsatellite instability (MSI), driving targeted, personalized cancer treatments.
Cube is the investment office founded by Rancilio family
Show more...Investment focus
- Industry: E-Commerce, Software, Financial Services
- Stage:Seed, Series A, Series B
- Geography: United States, Italy, Germany
Investor stats
- Total investments: 66
- Lead/follow: no public data
Portfolio highlights
- Convoy — Using technology and automation, the Convoy Platform seamlessly connects carriers with shipments from brokers across the nation.
- FinCompare - Smarter Business Finance — FinCompare was founded by Stephan Heller and is a fintech startup that helps businesses to find, compare, and close the financing solutions. Via the online platform, companies can access a wide range of financing options. They can independently compare offers from well-known banks, fintechs, and alternative financial services providers in Germanyand close the financing. The company also offers a convenient one-stop destination for all financing questions relating to the company.FinCompare financing solutions including corporate loan, factoring, company leasing/hire purchase, warehouse financing, fine trading/purchase financing, and mezzanine capital. It simplifies the financing process with its digital application process and can thus provide your company financing. The company allows SMEs to receive and compare various offers for loans.FinCompare was founded in October 2016 by Stephan Heller and is headquartered in Berlin, Germany.
- Finom — Finom is an online payment solution for entrepreneurs that makes it easy to open a business account and securely manage their finances.
Sefea Impact is an asset management company that setting up and managing closed-end alternative investment funds. It aims to generate social impacts through fundamental tools such as tailored finance, technical assistance, and impact measurement.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- BionIT Labs — We apply IT to Bionics in order to Turn disabilities into New Possibilities
Simon Fiduciaria nasce nel 1986 per prestare servizi fiduciari a importanti gruppi familiari, imprenditori e professionisti, a livello nazionale ed estero.
Show more...Investment focus
- Industry: Therapeutics, Simulation, Biotechnology
- Stage:Seed, Series B
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 7
- Lead/follow: no public data
Portfolio highlights
- MgShell — MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures.
- Soource — Soource is a B2B Saas product that uses AI applications to help purchasing managers to discover the best market solutions through extensive global research and automated email negotiations with thousands of suppliers worldwide.
- Annaida Technologies — Annaida Technologies has developed a groundbreaking device, EmbryoSpin, that performs microscopic Nuclear Magnetic Resonance (“µNMR”) at a scale 10-fold better than existing technologies.
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Medicud — Medicud develops a device for treating wounds with negative pressure dressing.
Estor is a Investment Firm.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Endostart — Endostart development and manufacturing of a new generation medical devices for gastrointestinal endoscopy.
Spindial Group
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Glomeria Therapeutics — Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis.Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Manufacturer of medical devices for home rehabilitation
Show more...Investment focus
- Industry: Wellness, Health Care, Medical Device
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Euleria Health — Devices and technologies for more accessible and measurable rehabilitation and telerehabilitation at the service of clinics and movement experts, in the clinic and at home.
Fondazione Golinelli was born in Bologna in 1988 by the will of the entrepreneur and philanthropist Marino Golinelli with the aim to promote education and training, to promote the culture, to foster intellectual growth and ethics of young people, the citizens of tomorrow.
Show more...Investment focus
- Industry: FinTech, Financial Services, AgTech
- Stage:Seed, Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 5
- Round size: Seed $146k–$534k
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Biorfarm — Adotta il tuo Albero, crea il tuo Campo Digitale e ricevi a domicilio la tua frutta biologica. Solo con Biorfarm puoi seguire la crescita dei tuoi frutti!
- EvenFi — Criptalia uses blockchain technology to connect businesses that have projects to be funded with people and organizations who are looking for high-yield investments. We offer an online platform where companies publish their innovative ideas and industrial improvement projects. Investors, people, and institutions can fund these projects by lendingmoney in exchange for a higher interest rate.
- Latitudo40 — Empower sustainable growth with AI-driven satellite insights from Latitudo 40. Unlock precise, real-time data for smarter urban planning, climate risk management, and industry innovation. Enhance resilience and lead with confidence.
Embed Capital directly invests in startups, established or in the process of creation.Embed is mainly focused on innovative companies that:- Are active in the so-called “real economy” sectors: industrials, technology, environment, services, retail or social;- Are characterized by simple and intuitive business models and valuepropositions, and operate in markets or market segments featuring high growth potential;- Present a clear competitive advantage and high barriers-to-entry;- Are cash-generative in the medium term.Given that Embed Capital is not a closed-end fund, it doesn’t have specific time-constrains and it can assess on a project-by-project basis to determine the best time to sell a participation, and sign customized agreements with the entrepreneurs.
Show more...Investment focus
- Industry: Information Technology, Mobile, Health Care
- Stage:Seed, Pre-Seed
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 17
- Round size: Seed $132k–$2.1M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Piantando — Piantando sells plants connected to initiatives for the preservation of the planet engaged in the following areas: land, water, climate, biodiversity and local communities. Each plant is equivalent to a transparent and unique contribution, destined to an initiative certified by our Value Chain. Everyone become ambassadors of a new way of livinggreen and understanding their commitment to the planet.
- FrescoFrigo - Healthy food close to you — FrescoFRIGO is a smart fridge with fresh and quality products designed for the needs of worker. Improve everyday lifestyle, through automated proximity selling of good, fresh and healthy product, innovating technology and user experience.
- The Nemesis — The Nemesis is the playground for play-to-earn games and adventures in virtual worlds. Accessible on both mobile and desktop.
Sviluppo Imprese Centro Italia is an independent asset management company founded in Florence in 1998. Active in the Private Equity and Venture Capital sector, it currently manages four closed-end funds for a total value of around 140 million euro and has already carried out numerous operations. in the capital of companies operating in variousindustrial sectors, from the most traditional to high-tech. The mission of SICI is to encourage the development of unlisted SMEs in Central Italy through the contribution of financial resources intended to strengthen their capital and financial structure. SICI intends to represent a Growth Partner for the investee companies and a strategic operator in the creation of value for the territory with an impact on the economic and social fabric in terms of competitiveness of the economic system, employment, entrepreneurial and managerial culture. Business Development Central Italy is an independent Italian managing closed-end funds company. Established in Florence in 1998, SICI has 4 Private Equity and Venture funds under management with a total committed capital of 140m Euros.
Show more...Investment focus
- Industry: Software, Food Processing, Food and Beverage
- Stage:Seed, Angel
- Geography: Italy
Investor stats
- Total investments: 10
- Round size: Seed $584k–$668k
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Recuperiamo srl — Recuperiamo srl is a food industry founded to prevent and reduce waste throughout the food chain. They are involved in the food industry through the Regusto brand. They can use geolocation to report on last-minute offers for their dishes.
- Dora Bruschi 1934 — Dora Bruschi 1934 is a cosmetics company that provides cosmetics, beauty, and make-up products with tailor-made formulas.
- Gastronomia Toscana — Gastronomia Toscana is a food company that manufactures and supplies a wide range of pre-cooked meals.
Global Payments SpA is a wholly-owned subsidiary of TAS Group.
Show more...Investment focus
- Industry: FinTech, Wearables, Biometrics
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Flywallet — Flywallet founded by Lorenzo Frollini at the end of 2018 together to Arianna Ludovica Frollini, Matteo Egidi e Alessandro Massimiani, is an innovative startup that connects payment, mobility and health services by enclosing them in a single ecosystem and putting safety first, thanks to biometrics and proprietary wearable and IoT technologies. Ithas created Keyble, a new type of wearable that adapts to the user's lifestyle, created with eco-sustainable materials and inspired by made-in-Italy fashion. It consists in a smart module which can be inserted into fashion accessories such as bracelets or watch straps and is equipped with biometric sensors for user authentication and to monitor their health. Through the fingerprint or heartbeat via ECG, the user enables payments in stores, passwordless access to online services, ticketing for public transport, loyalty cards, access to gyms, offices and homes, car door locks and digital identity. In Q1 2022, the wearable will reach the certification for medical device for performing the analysis of cardiac arrhythmias, blood oxygen saturation and body temperature. Flywallet offers a unique model of "Biometric Wearable Platform as Service" aimed to electronic money and payment institutions, banks, insurance companies and firms. The Flywallet Platform includes the world's 1st wallet for tokenizing payment cards on wearables equipped with biometric authentication and allows Partner companies to deliver new types of services through API connection in a simple and secure way.
RedSeed Ventures is a Venture Capital firm investing in Early Stage Companies and Scaleups, in Europe and more particularly in Italy.
Show more...Investment focus
- Industry: Software, Information Technology, Retail
- Stage:Seed, Series A, Series B
- Geography: Italy, Israel, United States
Investor stats
- Total investments: 11
- Round size: Seed $669k–$12M; Series A $2.2M–$16M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Leaf Space — Leaf Space offers a global network of ground stations, providing seamless, cost-effective satellite communication with scalable solutions for all mission sizes.
- Yope — Salo is a discussion platform that erases the borders for people with diverse opinions to let anyone speak up and be heard.
- CyberRidge — CyberRidge is a deep-tech cybersecurity firm that develops photonic encryption to protect data privacy.
RocaX > Is building a solid and much needed bridge for startups between the support offered by business angels and the upper stage VCs. Learn more!
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: Romania, United Kingdom, Italy
Investor stats
- Total investments: 35
- Round size: Seed $150k–$2.6M; Pre-Seed $55k–$915k; Convertible Note $165k–$1.1M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $4.7M in 2019
Portfolio highlights
- FilmChain — Managing end-to-end financial transactions for creative industries
- Bunnyshell — Bunnyshell is a a simple and fast cloud-agnostic DevOps automation platform to deploy, scale, and optimize your applications.We provide easy infrastructure management on multiple clouds , application management and DevOps Tools.Bunnyshell increases speed, performance, and scalability & works on the most popular major clouds: AWS, DigitalOcean, Azure, Linode, Vultr, UpCloud.Our platform allows you to focus on growing your app, while we take care of the rest: real time monitoring, auto scaling, smart self-healing servers, one click deployment. Backed by 24/7 real time support.
- Kinderpedia — Free remote video teaching on Kinderpedia, Daily attendance, gradebook and reports and 20 more functionalities for connected education.
The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, Italy, Germany
Investor stats
- Total investments: 34
- Round size: Seed $131k–$1.9M; Series A $1.8M–$4.1M
- Lead/follow: 68% lead, 32% follow
Portfolio highlights
- Gendius — Gendius was founded by Chris Genders and Rory Cameron with a view to making living with diabetes easier. The company has developed Intellin® - an App platform that uses an individual’s clinical history to predict those areas most likely of developing complications from their diabetes i.e. their individual high-risk areas. The platform then focussesthe individual on clinically validated tasks and measures to slow their progression in these areas.
- Maxwellia — A contraceptive pill, Lovima, is now available to buy without a prescription.
- Nexus Labs (Surgical Teaching) — Nexus Labs is an interactive learning resource for medical students.
Fountain Healthcare Partners is an Irish based life science venture capital fund. Fountain is exclusively focused on the life science sector. Specific areas of interest to them are: specialty pharma, medical devices, biotechnology and diagnostics. They will deploy the majority of their capital in Europe with a strong focus on Ireland.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: Ireland, United States, France
Investor stats
- Total investments: 50
- Round size: Series A $6.3M–$43M; Series B $5.5M–$68M; Series C $3.3M–$110M
- Lead/follow: 42% lead, 58% follow
- Last fund: May invest from a new fund soon — raised $128M in 2019
Portfolio highlights
- Palyon Medical — Palyon Medical Corporation is a medical device company developing technologies for the treatment of chronic pain, spasticity and other neurological diseases.
- Neuromod Devices — Neuromod is the global medical device company that developed Lenire, the FDA Approved tinnitus treatment device.
- Vivasure Medical — Pioneering the Future of Large-Bore Vessel Closure for Arterial and Venous Access. The first and only 100% bio-absorbable, sutureless patch..
Atlante Ventures is a leading Italian VC fund, operated by IMI Fondi Chiusi SGR, part of Intesa Sanpaolo Group.
Show more...Investment focus
- Industry: Software, Hardware, Biotechnology
- Stage:Seed, Series A
- Geography: Italy, United States, Israel
Investor stats
- Total investments: 46
- Round size: Seed $150k–$3.5M; Series A $1.5M–$3.3M
- Lead/follow: 22% lead, 78% follow
- Last fund: May invest from a new fund soon — last raise in 2007
Portfolio highlights
- ADmantX — A NEW ERA OF AUDIENCE TARGETINGADmantX is a contextual analysis and data provider that brings audience targeting to a new level. Awarded patent for semantic advertising technology, the company offers a cookie-less solution that allows publishers, ad networks and exchanges, brand managers and agencies to develop more effective online adcampaigns leveraging semantic understanding, natural language processing and sentiment analysis. Founded in Italy as a spin-off of the leading semantic company Expert System, ADmantX is active in Europe and US. Worldwide customers include NBCUniversal, Integral Ad Science, Networked Insights, Banzai, Cadreon, Amnet, Sojern, Media IQ and ADmantX solutions are integrated in key DSP players such as Turn, Adform and AppNexus.
- Remocean — remocean was founded in 2010, after ten years of joint research activity between the IREA-CNR institute (Institute for Electromagnetic Sensing of the Environment) in Naples and the INSEAN institute in Rome.
- YOGITECH — Notizie e approfondimenti di Tecnologia
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!RoboIT is the National Technology Transfer Hub for Robotics and Industrial Automation.
Show more...Investment focus
- Industry: Manufacturing, Robotics, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 10
- Round size: Seed $867k–$81M; Series A $5.8M–$6M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- K3RX — K3RX products for thermal protection systems of the next generation of hypersonic vehicles and rocket motor inserts of satellite launchers demonstrate their performance. K3RX manufactures tiles in uhtcmc material, rocket nozzles, screws, nuts, and support mechanical connectors.
- Wearable Robotics — Wearable Robotics produces and develops wearable robotic systems and exoskeletons for rehabilitation, assistance and human-power augmentation.
- Generative Bionics — Generative Bionics develops humanoid robots that integrate robotics, advanced artificial intelligence, and design for safe, reliable operation in real-world industrial environments.
Lazio Innova is a venture capital firm with its headquarters in Rome in Italy. The firm provides services in areas such as credit support and guarantees, interventions in risk capital, internationalization services, promotion of business networks and services for the creation and enterprise development.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Pre-Seed, Grant
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 34
- Round size: Seed $400k–$1.9M; Grant $22k–$121k; Pre-Seed $53k–$518k
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — raised $27M in 2018
Portfolio highlights
- HEU — HEU is a legaltech company that automates and manages legal documents and allows users to edit and share them.
- Tech4All — We support the study by using AI.
- GeneSys Bio — Antimicrobial Resistance (AMR) is a global health emergency projected to cause 10 million deaths annually by 2050. The crisis is fueled by slow, conventional diagnostics that take 3-5 days, forcing the empirical use of broad-spectrum antibiotics and accelerating the spread of superbugs.GeneSys Bio is commercialising a breakthrough solution: afully automated, sample-to-result molecular diagnostic platform that identifies infectious pathogens and their critical antibiotic resistance genes in under 30 minutes with >99% sensitivity and specificity. Our portable, laptop-sized device combines proprietary nucleic acid amplification with an AI-driven engine to deliver clear, actionable results directly to clinicians, veterinarians, and public health officials.Our platform is a modular "One Health" solution, adaptable via disease-specific kits for human, veterinary, and environmental applications. We are entering the market with a diagnostic for Urinary Tract Infections (UTIs), a condition affecting over 500 million people annually and a primary driver of antibiotic misuse. By enabling targeted therapy at the first patient encounter, our platform is set to reduce treatment costs by up to 13%, cut follow-up visits, and decrease mortality from complicated infections by 50%.GeneSys Bio is positioned to capture a significant share of this market by bridging the critical gap between speed, laboratory-grade accuracy, and accessibility. We are not just creating a device; we are building the future of decentralized infectious disease diagnostics to safeguard global health for generations to come
The Amazon Alexa Fund is Amazon’s venture capital fund investing in artificial intelligence, frontier tech, voice, robotics, and digital health across consumer and enterprise. We invest in early- to growth-stage companies globally. To learn more, visit us at alexafund.com.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 139
- Round size: Seed $120k–$5.7M; Series A $5.1M–$46M; Series B $11M–$120M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $100M in 2017
Portfolio highlights
- Endel — Personalized soundscapes to help you focus, relax, and sleep. Backed by neuroscience.
- Hearvana — Hearvana is a IT consulting company.
- Fable Studio — Fable is building next-generation AI authoring tools to create interactive characters who can live, learn and make decisions with us.
Cysero is a venture capital fund focused on the robotics and cybersecurity sectors. The fund was established in October 2020 and managed by AVM Gestioni SGR S.p.A. Manager EuVECA Società Benefit and jointly promoted with Kilometro Rosso, Bergamo's science and technology park.
Show more...Investment focus
- Industry: Robotics, Information Technology, Autonomous Vehicles
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Italy, United States
Investor stats
- Total investments: 9
- Round size: Seed $2.1M–$5.5M; Venture - Series Unknown $1.4M–$4.3M
- Lead/follow: 89% lead, 11% follow
Portfolio highlights
- Octostar — Octostar is the AI-powered investigative intelligence platform for law enforcement, national security, and financial institutions. Connect the dots and discover the facts across petabytes of data.
- TrueScreen — Certify photo, video, screenshot, document and audio recording with legal value. Prevent fraud and disputes obtaining indisputable evidences
- Next Generation Robotics — Next Generation Robotics is a company that manufactures robotic systems for inspection and monitoring for the railway industry.
Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Private Equity, Series A
- Geography: France, United States, Germany
Investor stats
- Total investments: 185
- Round size: Series A $7M–$83M; Series B $14M–$85M; Private Equity $110M–$237M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $466M in 2022
Portfolio highlights
- Cyllene Therapeutics — EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.
- Inventiva Pharma — Inventiva Pharma is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical needs in the areas of fibrosis, lysosomal storage disorders and oncology.They have built a pipeline backed by a discovery engine with an extensive library ofproprietary molecules, a wholly-owned research and development facility and a team with significant expertise and deep experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging these assets and expertise, they are advancing two clinical candidates in three indications, as well as a deep pipeline of earlier stage programs.
- Rivermark Medical — Rivermark Medical develops a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that restores urinary function. Developed by urologists to reliably reduce BPH symptoms with minimal side effects.
SFEM Italia is a family office that chooses, manages, and oversees the investments of the Stevanato Family. SFEM is dedicated to the management of all non-core investments for the group including alternative investments such as real estate, private equity, and venture capital. It was founded in 2012 and is headquartered in Milan, Italy.
Show more...Investment focus
- Industry: Big Data, Software, Health Care
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- PatchAi — Improve patient engagement and experience in clinical trials and standard care. Discover Patchai solution.
UV-Cap is a German family office that invests in mid-size cooperations that have great potential in their markets in the "b-to-b" business. It is based in Ravensburg, Germany.
Show more...Investment focus
- Industry: Personal Health, Big Data, Software
- Stage:Seed, Series A
- Geography: Italy, Germany
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- PatchAi — Improve patient engagement and experience in clinical trials and standard care. Discover Patchai solution.
- Perfood — Perfood is a digital therapeutic startup that identifies what actions need to take on a personalized level, to prevent or fight diseases. Using sensors, lab results, and holistic analyses, they derive therapeutic angles and deliver them in a slick, easy-to-use way, making them accessible for all patients. They call this approach digitaltherapeutics. A digital solution that is just as effective as a drug. But without side effects.
Si14 is a visionary original design and development laboratory for novel technology products that enhance the way we live, work and play. Founded in 2008 and based in Padova, Italy, Si14 turns inspiration into the realization of compelling, cutting-edge products and services that help people connect with their activities and their world, empowerenterprises in realizing greater efficiencies, improve access to vital health screening services for millions worldwide, and much more.
Show more...Investment focus
- Industry: Medical, mHealth, Diabetes
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- D-EYE — D-EYE's technology enables healthcare professionals all over the world to quickly screen for problems, photograph them and then distribute them digitally via various secure wireless solutions. They design and manufacture diagnostic instruments.
SIMEST is a financial firm focused on the development and promotion of Italian enterprises abroad. Simest acquires up to 49% of the equity capital of foreign firms in countries outside the European Union, whether wholly-owned by Italian companies or set up as joint ventures with local partners. It also provides start-up and growth capital financingas well as participating in buyouts.Geographically it invests in non-EU countries, focusing on BRIC, Americas and Middle-East. Simest also provides Italian companies seeking to internationalize their businesses with technical assistance and advisory services.Simest is a member of the European Development Finance Institutions (EDFI) and the Italian Venture Capital and Private Equity Association (AIFI).
Show more...Investment focus
- Industry: Manufacturing, FinTech, Aerospace
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Italy, San Marino, Saudi Arabia
Investor stats
- Total investments: 20
- Round size: Series A $4.1M–$17M; Series B $12M–$24M; Venture - Series Unknown $4.7M–$6.5M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- DRONUS — Dronus provides inspection, safety, and smart city capabilities from an innovative, minimally invasive base that guarantees the drone's flight stability and safety during take-off and landing, even in difficult climatic conditions.
- Wearable Robotics — Wearable Robotics produces and develops wearable robotic systems and exoskeletons for rehabilitation, assistance and human-power augmentation.
- EIS Wire and Cable — EIS Wire & Cable provides extraordinary customer service, short lead times, competitive pricing and the ability to meet your custom or private label requirement
F3F
Show more...Investment focus
- Industry: Hardware, Hospital, Software
- Stage:Series A, Series B, Series C
- Geography: Italy
Investor stats
- Total investments: 4
- Round size: Series A $3.3M–$9.2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
Medical Device VC funding in Italy at a glance
Stats across 99 deals from 105 investors.
Access all 105 VC funds in Italy Medical Device startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device VC Funds in Italy investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 105 VC funds investing in Italy Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!